Wealth Enhancement Advisory Services’s Verona Pharma VRNA Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio VRNA Stock Details VRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,077	Closed	-$115K	–	3809
2025 Q3	$115K	Sell	1,077 -3,172	-75%	-$331K	﹤0.01%	3308
2025 Q2	$389K	Buy	+4,249	New	+$315K	﹤0.01%	2417

Other funds holding VRNA

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Wealth Enhancement Advisory Services's VRNA Position: Q4 2025 in Review

Wealth Enhancement Advisory Services sold out of Verona Pharma (VRNA) in Q4 2025, closing a stake of 1,077 shares — an estimated $115K sold.

Wealth Enhancement Advisory Services first reported a position in VRNA in Q2 2025 and held it in 2 quarters. The position peaked at $389K in Q2 2025. 1 fund tracked by Wall St. Rank holds VRNA as of Q4 2025.

Wealth Enhancement Advisory Services reported no remaining Verona Pharma position as of Q4 2025 after selling out during the quarter.
Wealth Enhancement Advisory Services sold 1,077 Verona Pharma shares in Q4 2025, an estimated $115K.
Wealth Enhancement Advisory Services first reported a position in Verona Pharma in Q2 2025 and held it in 2 quarters.
Wealth Enhancement Advisory Services's Verona Pharma position peaked at $389K in Q2 2025.
1 fund tracked by Wall St. Rank held Verona Pharma as of Q4 2025.

Based on Wealth Enhancement Advisory Services's 13F filing for Q4 2025, filed 8 Jan 2026.